Unitree Robotics: The Humanoid Robot Industry Is Still in the Early Stages of Commercialization

On October 20, Unitree Robotics announced that the accumulated deviation of its closing price gains over three consecutive trading days exceeded 30%, qualifying as an abnormal fluctuation in stock trading. The humanoid robot industry is still in its early commercialization phase, with uncertainties regarding technological maturity, downstream market demand development, and supply chain support capabilities. Should the industry's large-scale commercial deployment progress slower than anticipated, the company's future revenue expansion and earnings realization may be negatively impacted, carrying investment risks of valuation correction.